Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment‐free remission period after imatinib discontinuation: Results of the French Nilo post‐ STIM study
- Resource Type
- Source
- British Journal of Haematology.
- Subject
Hematology - Language
- ISSN
- 1365-2141
0007-1048